Cite
First case of hemicrania continua responsive to galcanezumab.
MLA
González-Quintanilla, Vicente, et al. “First Case of Hemicrania Continua Responsive to Galcanezumab.” Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 42, no. 11, Nov. 2021, pp. 4775–76. EBSCOhost, https://doi.org/10.1007/s10072-021-05476-9.
APA
González-Quintanilla, V., Pérez-Pereda, S., Fontanillas, N., & Pascual, J. (2021). First case of hemicrania continua responsive to galcanezumab. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(11), 4775–4776. https://doi.org/10.1007/s10072-021-05476-9
Chicago
González-Quintanilla, Vicente, Sara Pérez-Pereda, Noelia Fontanillas, and Julio Pascual. 2021. “First Case of Hemicrania Continua Responsive to Galcanezumab.” Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42 (11): 4775–76. doi:10.1007/s10072-021-05476-9.